Wearable Injector Devices Market, By Injector Type (On Body & Off Body), By Usage (Disposable, Reusable), By Technology (Spring Based, Motor-Driven, Rotary Pump, Expanding Battery, Smart Connectivity Options & Others) & By Therapeutic Area (Oncology, Diabetes, Cardiovascular Diseases, Autoimmune Disorder, Infectious Diseases & Others) - Growth, Future Prospects, and Competitive Analysis, 2017 -2025

The report titled “Wearable Injector Devices Market: Growth, Future Prospects, and Competitive Analysis, 2017 -2025” offers strategic insights into the overall wearable injector devices market along with the market size and estimates for the duration 2015 to 2025. The said research study covers in-depth analysis of wearable injector devices market segments based on injector type, usage, technology, therapeutic area end users and different geographies further segmented by countries. Wearable injector’s also known as large volume injectors are the latest trend in the injectable device market. These devices permit the injection of large volume of dosage via subcutaneous route for long duration, which offers benefits to drug developers, clinicians and patients. Most of the instances biologic therapeutics are parenteral delivery wherein high volume injection doses are often needed. Biologic therapeutics development is growing at a faster pace compared to other medication forms, this growth in the biologic market is said to in parallel drive the emergence of wearable injectors.

For the purpose of this study, the global wearable injector device market is segmented on the basis of injector type, usage, smart connectivity options, technology, therapeutic area & end users. Injector type is further segmented into On Body & off Body. Based on Usage devices are further segmented into Disposable & Reusable devices. By technology devices are segmented into spring based, motor-driven, rotary pump, expanding battery, smart connectivity options & others. By therapeutic area devices are segmented into oncology, diabetes, cardiovascular diseases, autoimmune disorder, infectious diseases & others. Market size estimates and forecast for these segments for the period 2015 to 2025 are provided in terms of US$ Mn along with the respective compounded annual growth rates (CAGRs) for the period 2017 to 2025, considering 2016 as the base year.

The geographical segmentation of the global wearable injector devices market comprised regions such as North America, Europe, Asia-Pacific, Latin America & Middle East and Africa. Each geographical region is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, Brazil, Mexico, Saudi Arabia, South Africa, and other countries. Market size and forecast for these segments during 2015 to 2025 and their CAGRs for the period 2017 to 2025 are provided in this report.

The wearable injector devices market is observed as the most diversified and competitive market comprising large number of players.  The market is dominated by several players, depending on their major competencies. The key players in this market are SteadyMed Therapeutics, Inc., UNILIFE CORPORATION, Sensile Medical AG, Insulet Corporation, Enable Injections, Becton, Dickinson and Company, West Pharmaceutical Services, Inc., Ypsomed, Amgen, Buhler Motor GmbH, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc., CeQur SA. & Others

Based on the technology of device, the global wearable injector devices market is segmented as follows:

  • Spring Based
  • Motor-Driven
  • Rotary Pump
  • Expanding Battery
  • Smart Connectivity Options
  • Others

Devices with spring based technology is presumed to account a larger market share owing to the increased demand for adhesive patches. Adhesive patches are convenient to use and ensure accurate dose administration subcutaneously. In the forecast period 2017-2025, the demand for devices with motor-driven technology is said to become predominant in the wearable injector devices market owing to its ability of accurate dose and self-administration of doses at pre-determined set timings.

Wearable Injector Devices Market

Based on therapeutic area, the global wearable injector devices market is segmented as follows:

  • Oncology
  • Diabetes
  • Cardiovascular Diseases
  • Autoimmune Disorders
  • Infectious Diseases
  • Others

In comparison with all the chronic diseases mentioned in this segment oncology predominates this segment and could grab a major share in wearable injector  devices market, owing to its rising prevalence along with increased approach for self-administration of medication in order to curb hospitalization costs. Diabetes holds second position in this segment, as wearable injectors have advantages over the insulin pumps. Other conditions would also slowly adopt the use of wearable injectors due to key factors such as patient friendly and reduces hospital costs. The demand would increase further once the reimbursement policies have been made lenient for these devices.

Wearable Injector Devices Market

For the purpose of this study, the global wearable injector devices market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Wearable Injector Devices Market

Wearable injectors are the latest technological advancements which enables to inject large volume doses via the subcutaneous route. Based on geographies, the wearable injector devices market are segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Among the mentioned regions, North America shows higher dominance in the wearable injector devices market. The factors that drives this market to a positive growth are a constant rising prevalence of chronic diseases, increase in advancement of technological development with smart connectivity options which helps remote monitoring by the caregivers, easy accessibility to latest technology and developed healthcare infrastructure. Asia-Pacific shows a positive growth in the forecast periods, 2017-2025 owing to catalysts such as rise in prevalence of technologically forward industrial pool in countries like Japan and China. Developing nations such as Latin America and Middle East & Africa show a sluggish growth in the forecast period which could be attributed to a slower acceptability and availability of developed technologies.

Choose License Type
Published Date:  Nov 2017
Category:  Medical Devices
Report ID:   58775
Report Format:   PDF
Pages:   120
Rating:    4.5 (70)
Connect With Us
24/7 Research Support